Autoimmune disease Archives

Podcast 24 May 2024

How biotech is tackling myasthenia gravis

To talk about the disease, how it is being treated, and what is in the pipeline for future treatments, we had a conversation with Dana Vigier, head of Central Eastern and Northern Europe at Alexion.

May 24, 2024

In Depth 9 May 2024

BTK inhibitors: can these drugs tackle cancer and autoimmunity?

BTK inhibitors were first approved over a decade ago to treat a rare blood cancer. Now, they are in the running to treat a host of autoimmune diseases.

May 9, 2024 - 7 minutesmins - By Roohi Mariam Peter

Best in Biotech 23 Apr 2024

Eight biotechnology companies leading the charge in Poland

Discover eight biotech companies at the forefront of Poland’s emerging biotech sector, which is becoming a hotspot for startups.

April 23, 2024 - 7 minutesmins - By Jules Adam

In Depth 27 Mar 2024

Are new treatments for multiple sclerosis on the horizon?

As the wait for new multiple sclerosis treatments continue, here are some ongoing clinical trials that hold promise.

March 27, 2024 - 10 minutesmins - By Roohi Mariam Peter

In Depth 7 Mar 2024

Can AbbVie’s legacy live beyond its once best-selling drug Humira?

The sales of AbbVie’s Humira, once a best-seller, have dropped. Now, with a new CEO announced, things are about to change for the company.

March 7, 2024 - 8 minutesmins - By Roohi Mariam Peter

Protein inhibitors: cracking the code of disease mechanisms

Explore how protein inhibitors revolutionize disease understanding, by unlocking the secrets of disease pathways.

February 27, 2024 - 4 minutesmins - By Ute Boronowsky

Podcast 2 Feb 2024

BioSenic showcasing knee osteoarthritis treatment

Explore a groundbreaking approach to knee osteoarthritis treatment with BioSenic’s JTA-004. Listen to our podcast to learn more!

February 2, 2024

Podcast 8 Dec 2023

Can worms provide treatments for some diseases?

U.S. company Holoclara is looking to tackle diseases through the development of worm-derived therapeutics. Allergic and autoimmune diseases were first described in the early 1900s, which Holoclara said is the same time that gut-resident worms such as the roundworm, Caenorhabditis elegans, were removed from people in industrialized countries. The company, led by CEO Andrea Choe, […]

December 8, 2023

In Depth 12 Oct 2023

Can immunometabolism-based therapies transform the way cancers and autoimmune diseases are treated?

The immune system protects our bodies from foreign invaders, but sometimes, when it malfunctions, it can result in life-threatening autoimmune disorders. But what if the immune system could be regulated to counter these diseases? Immunometabolism, an emerging field in therapeutics, aims to rein in autoimmunity altogether. According to Neil Weir, chief executive officer (CEO) of […]

October 12, 2023 - 9 minutesmins - By Roohi Mariam Peter

Best in Biotech 19 Sep 2023

Five biotech companies taking Los Angeles by storm

Known throughout history for being home to the iconic scene of Hollywood, in recent years Los Angeles has also become a thriving biotech hub, after years of playing second fiddle in the U.S. to the likes of South San Francisco and Boston. In this article, we take a look at five of the best Los […]

September 19, 2023 - 6 minutesmins - By Willow Shah-Neville

Startup Scout 13 Sep 2023

PIM kinase inhibition: a Swiss startup’s unique approach to tackling complex autoimmune disorders

A healthy immune system is supposed to defend the body against disease and infection, but in autoimmune diseases, the immune system malfunctions, and instead attacks the body’s healthy cells, tissues, and organs. Despite recent progress in therapeutic options for autoimmune disorders, a significant unmet need remains, which is why Mysthera Therapeutics is aiming to take […]

September 13, 2023 - 7 minutesmins - By Willow Shah-Neville

Best in Biotech 23 Aug 2023

Latest advancements in psoriasis research over the past year

Psoriasis, an autoimmune condition that causes flaky patches of skin to form scales, occurs when the body’s immune system attacks its own healthy skin cells. And because people with psoriasis have an increased production of skin cells, these cells – which are normally renewed every three to four weeks – regenerate in under a week. […]

August 23, 2023 - 8 minutesmins - By Roohi Mariam Peter

Resources

Categories

T cell engagers: A promising, fast-growing field for cancer and autoimmune disease treatments

The biggest biotech funding rounds in February 2025

Approaches

Therapeutic areas

Grab your free report on 3D organoids and explore their future potential

World Cancer Day: trends in cancer therapeutics to look forward to in 2025

R&D

BD

World biotech leaders

Connect with decision-makers and researchers worldwide for collaborative opportunities

Company

Join Us

Subscribe to our newsletter

Advertise with us

T cell engagers: A promising, fast-growing field for cancer and autoimmune disease treatments

The biggest biotech funding rounds in February 2025

Grab your free report on 3D organoids and explore their future potential

World Cancer Day: trends in cancer therapeutics to look forward to in 2025

Connect with decision-makers and researchers worldwide for collaborative opportunities

Subscribe to our newsletter

Advertise with us

Autoimmune disease

How biotech is tackling myasthenia gravis

BTK inhibitors: can these drugs tackle cancer and autoimmunity?

Eight biotechnology companies leading the charge in Poland

Are new treatments for multiple sclerosis on the horizon?

Can AbbVie’s legacy live beyond its once best-selling drug Humira?

Protein inhibitors: cracking the code of disease mechanisms

BioSenic showcasing knee osteoarthritis treatment

Can worms provide treatments for some diseases?

Can immunometabolism-based therapies transform the way cancers and autoimmune diseases are treated?

Five biotech companies taking Los Angeles by storm

PIM kinase inhibition: a Swiss startup’s unique approach to tackling complex autoimmune disorders

Latest advancements in psoriasis research over the past year

Subscribe to our newsletter to get the latest biotech news!

T cell engagers: A promising, fast-growing field for cancer and autoimmune disease treatments

The biggest biotech funding rounds in February 2025

Grab your free report on 3D organoids and explore their future potential

World Cancer Day: trends in cancer therapeutics to look forward to in 2025

Connect with decision-makers and researchers worldwide for collaborative opportunities

Subscribe to our newsletter

Advertise with us

T cell engagers: A promising, fast-growing field for cancer and autoimmune disease treatments

The biggest biotech funding rounds in February 2025

Grab your free report on 3D organoids and explore their future potential

World Cancer Day: trends in cancer therapeutics to look forward to in 2025

Connect with decision-makers and researchers worldwide for collaborative opportunities

Subscribe to our newsletter

Advertise with us

Subscribe to our newsletter

Get the latest biotech news directly to your inbox!

Newsletter Signup - Footer

Subscribe to our newsletter to get the latest biotech news!